April 23rd, 2019


Volume 50
Number 1
   
 Editorial
1
Lawrence D. Devoe, M.D.


 Original Articles
3
Annarosa Virgili, M.D., Arianna Levratti, M.D., Andrea Marzola, M.D., and Monica Corazza, M.D.
The percentage of plasma cells is the most important parameter in making the diagnosis of PCV.


8
Cindi Lewis, M.D., Carla Martinez, M.D., and Rebecca Rogers, M.D.
A well-designed treatment protocol may help provide evidence-based, consistent treatment for patients requiring care who also have identified barriers to medical and surgical treatment.


13
Lori A. Boardman, M.D., Sc.M., Debra L. Goldman, M.D., Amy S. Cooper, C.R.N.P., Walter W. Heber, Sc.M., and Sherry Weitzen, Ph.D.
Pregnant women with mildly abnormal cytology, as compared to those with HSIL, were less likely to have either antepartum or postpartum CIN 2 or worse.


19
Frank Lombano, M.D., and Barry S. Block, M.D.
Equations usable on personal digital assistants allow fetal growth assessments from ultrasound measurements without having to rely on tables or growth curves.


23
Asnat Walfisch, M.D., Mordechai Hallak, M.D., Shlomit Harlev, R.N., Moshe Mazor, M.D., and Ilana Shoham-Vardi, Ph.D.
Perineal stretching of >150% of its primary length during delivery was predictive of perineal lacerations requiring repair.


29
Dennis R. Scribner, Jr., M.D., Jonathan Baldwin, M.D., and Robert S. Mannel, M.D.
In a survey sent to all Society of Gynecologic Oncologists candidate members, the respondents indicated that formal didactics and improved mentoring in research were the 2 most common areas to improve.


35
Tak-hong Cheung, F.R.C.O.G., Keith Wing-kit Lo, M.R.C.O.G., So-fan Yim, M.R.C.O.G., Christopher Lam, F.A.C.B., Edith Lau, M.D., and Christopher Haines, M.D.
The beneficial effects of add-back therapy during GnRHa treatment are not increased by using 5 mg norethindrone as compared to 1 mg norethindrone acetate when combined with 2 mg estradiol.


41
Samuel S. Lentz, M.D.
The transvaginal approach using a peritoneal flap is the preferred method for repair of the simple posthysterectomy vesicovaginal fistula.


45
Sandro Rullo, M.D., Guiseppe Sorrenti, M.D. Massimiliano Marziali, M.D., Beatrice Ermini, M.D., Francesco Sesti, M.D., and Emilio Piccione, M.D.
The 2.7-mm hysteroscopes tend to lower the incidence of pain associated with office hysteroscopy, but menopause is the most important factor influencing the feasibility of the procedure.


49
Alexander Greenstein, M.D., Judith Sarig, R.P.T., B.Sc., Juza Chen, M.D., Haim Matzkin, M.D., Joseph B. Lessing, M.D., and Liora Abramov, M.D.
New-onset lower urinary tract symptoms developed after biofeedback therapy in women with primary vulvar vestibulitis syndrome and childhood nocturnal enuresis.


 Case Reports
53
CPT Benjamin D. Byers, MC, USA, COL William H. Barth, MC, USA, LTC Theresa L. Stewart, MC, USA, and MAJ Brian T. Pierce, MC, USA
This case demonstrates the in utero progression of hydranencephaly on ultrasound and magnetic resonance imaging.


57
Christopher W. Lipari, M.D., and Shawky Z. A. Badawy, M.D.
A 31-year-old woman with intermittent uterine hemorrhage from an arteriovenous malformation in a bicornuate uterus was treated effectively with uterine artery embolization.


61
Larissa S. Buccolo, M.D., and Anthony J. Viera, M.D.
A 25-year-old woman developed pruritic urticarial papules and plaques of pregnancy almost 2 weeks after delivery.


64
Najm S. Qureshi, M.R.C.O.G., and Anthony J. Tomlinson, M.R.C.O.G.
Use of corticosteroids in early-onset preterm cases of elevated liver enzymes/low platelet count syndrome may stabilize hematologic and biochemical abnormalities but not prevent fetal death.


67
Erdogan Aslan, M.D., Ebru Tarim, M.D., Esra Kilicdag, M.D., and Erhan Simsek, M.D.
Since autoantibodies against SS-A and SS-B seem to accompany congenital heart block, the primary goal of therapy should be preventing this untoward effect of the disease.


 Letter to the Editors
71
Bruce L. Flamm, M.D.


 

The opinions and statements in this journal are those of the authors and are not attributable to the sponsor, publisher, editors or editorial board of JRM. Product dosages, indications and methods of use referred to in the papers and discussions reflect the authors' clinical experience or are derived from other professional sources.